What laboratory and imaging studies should be ordered to evaluate for rheumatoid arthritis?

Laboratory and Imaging Evaluation for Rheumatoid Arthritis

Begin with conventional radiographs of hands and feet as your initial imaging, combined with serological testing for rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), inflammatory markers (ESR/CRP), and complete blood count. 1, 2

Laboratory Testing

Essential Serological Studies

• RF and ACPA testing are fundamental for diagnosis, though approximately one-third of RA patients remain seronegative 3, 2
• C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) provide objective measures of systemic inflammation and help establish diagnosis when combined with clinical findings 2
• Complete blood count with differential identifies anemia of chronic disease and monitors for cytopenias 2

Additional Laboratory Assessment

• Hepatic and renal function tests are necessary both for diagnosis and pre-treatment evaluation before initiating disease-modifying antirheumatic drugs 2
• Hepatitis B, hepatitis C, and tuberculosis screening should be performed if biologic therapy is anticipated 2
• Anti-carbamylated protein antibodies (anti-CarP) may be detected in up to 30% of ACPA-negative patients, though this is not yet standard practice 3

Imaging Studies

Initial Imaging Approach

• Conventional radiographs (CR) of hands and feet serve as the recommended initial imaging technique to detect structural damage, showing periarticular osteopenia, uniform joint space narrowing, and erosions 1
• Radiographs provide an overview of disease distribution involving the extremities, though erosions typically appear later in the disease course 1

Advanced Imaging for Enhanced Detection

Ultrasound (US) and MRI are superior to clinical examination for detecting joint inflammation and should be considered when more accurate assessment is needed 4, 1

Ultrasound Advantages

• US detects synovitis 2.18-fold more frequently than clinical examination in hands and wrists 4
• Power Doppler ultrasound identifies active inflammation; scores higher than grade 1 predict progression to RA with odds ratios of 9.9 (one joint) to 48.7 (more than three joints) 4
• US outperforms clinical evaluation in detecting both inflammation and structural damage while providing prognostic information 1
• Dorsal evaluation of finger joints is recommended over palmar approach 1

MRI Advantages

• MRI with intravenous gadolinium demonstrates higher diagnostic performance than ultrasound, especially in early RA 1
• Bone marrow edema on MRI is the strongest independent predictor of subsequent radiographic progression and should be used as a prognostic indicator 4, 1
• MRI synovitis also predicts erosive progression 4, 1
• Gadolinium is essential for detecting synovitis and tenosynovitis but less critical for identifying erosions 1

When to Use Advanced Imaging

• Consider US or MRI when conventional radiographs show no damage but clinical suspicion remains high, particularly in early RA 4
• Both modalities detect inflammation and structural damage more effectively than clinical examination, though evidence is inconclusive regarding which is superior 1
• MRI detects inflammation 2.20-fold more frequently than clinical examination 4

Common Pitfalls to Avoid

• Do not rely solely on serology—approximately one-third of RA patients are seronegative for both RF and ACPA 3
• Avoid delaying advanced imaging in seronegative patients with high clinical suspicion, as US and MRI can detect subclinical synovitis and early erosions 3
• Do not use CT routinely—while more sensitive for erosions than radiography and MRI, it cannot adequately demonstrate synovial hypertrophy and soft tissue abnormalities 1
• Bone scans and FDG-PET/CT are not routinely indicated for RA evaluation 1
• Mild synovial hypertrophy as an isolated US finding is not specific and has limited clinical relevance 1

Prognostic Imaging Features

MRI bone marrow edema is the most powerful predictor of erosive progression, with studies showing it as the only independent predictor at 2 and 5-year follow-up (coefficient 0.75-0.82, p<0.001) 4

• Baseline MRI bone marrow edema score >2 RAMRIS units predicts both radiographic (OR 2.77) and MRI erosive progression 4
• Absence of baseline MRI inflammatory changes makes radiological erosion development at 1 year highly unlikely (negative predictive value 0.92) 4
• Synovitis detected by MRI or ultrasound at baseline predicts erosive progression 4